Valbiotis SAS Valuation
| ALVAL Stock | EUR 1.39 0.02 1.46% |
Today, the company appears to be overvalued. Valbiotis SAS has a current Real Value of €1.12 per share. The regular price of the company is €1.39. Our model measures the value of Valbiotis SAS from inspecting the company fundamentals such as Shares Owned By Insiders of 8.39 %, current valuation of 35.17 M, and Return On Equity of -0.72 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Valbiotis SAS's price fluctuation is dangerous at this time. Calculation of the real value of Valbiotis SAS is based on 3 months time horizon. Increasing Valbiotis SAS's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Valbiotis SAS's intrinsic value may or may not be the same as its current market price of 1.39, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.39 | Real 1.12 | Hype 1.39 |
The intrinsic value of Valbiotis SAS's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Valbiotis SAS's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Valbiotis SAS helps investors to forecast how Valbiotis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Valbiotis SAS more accurately as focusing exclusively on Valbiotis SAS's fundamentals will not take into account other important factors: Valbiotis SAS Total Value Analysis
Valbiotis SAS is presently projected to have takeover price of 35.17 M with market capitalization of 50.38 M, debt of 6.13 M, and cash on hands of 541 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Valbiotis SAS fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
35.17 M | 50.38 M | 6.13 M | 541 K |
Valbiotis SAS Investor Information
The book value of the company was presently reported as 1.02. The company recorded a loss per share of 1.07. Valbiotis SAS had not issued any dividends in recent years. The entity had 112:111 split on the 14th of October 2019. Based on the key indicators related to Valbiotis SAS's liquidity, profitability, solvency, and operating efficiency, Valbiotis SAS is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Valbiotis SAS Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Valbiotis SAS has an asset utilization ratio of 7.18 percent. This connotes that the Company is making €0.0718 for each dollar of assets. An increasing asset utilization means that Valbiotis SAS is more efficient with each dollar of assets it utilizes for everyday operations.Valbiotis SAS Ownership Allocation
The market capitalization of Valbiotis SAS is €50.38 Million. Valbiotis SAS has 8.39 % of its outstanding shares held by insiders and 7.32 % owned by institutional holders. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Valbiotis SAS Profitability Analysis
The company reported the revenue of 2.05 M. Net Loss for the year was (8.68 M) with profit before overhead, payroll, taxes, and interest of 298 K.About Valbiotis SAS Valuation
The stock valuation mechanism determines Valbiotis SAS's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Valbiotis SAS based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Valbiotis SAS. We calculate exposure to Valbiotis SAS's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Valbiotis SAS's related companies.Valbiotis SA develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients. Valbiotis SA was founded in 2014 and is based in Prigny, France. VALBIOTIS is traded on Paris Stock Exchange in France.
8 Steps to conduct Valbiotis SAS's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Valbiotis SAS's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Valbiotis SAS's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Valbiotis SAS's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Valbiotis SAS's revenue streams: Identify Valbiotis SAS's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Valbiotis SAS's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Valbiotis SAS's growth potential: Evaluate Valbiotis SAS's management, business model, and growth potential.
- Determine Valbiotis SAS's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Valbiotis SAS's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Valbiotis Stock Analysis
When running Valbiotis SAS's price analysis, check to measure Valbiotis SAS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Valbiotis SAS is operating at the current time. Most of Valbiotis SAS's value examination focuses on studying past and present price action to predict the probability of Valbiotis SAS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Valbiotis SAS's price. Additionally, you may evaluate how the addition of Valbiotis SAS to your portfolios can decrease your overall portfolio volatility.